Guidance and evidence for healthcare professionals on the use of antivirals for the treatment and prophylaxis of influenza. See also
Report that presents the models of delivery, issues, barriers and innovative solutions of community-based strength and balance programmes. Falls are not an inevitable part of ageing and can be prevented. Although there are some NHS rehabilitation services that provide strength
Data on the ovalbumin content of the influenza vaccines for the 2018 to 2019 flu season. The table lists all of the ovalbumin content of the influenza vaccines that are marketed in the UK for the 2018 to 2019 flu vaccination
Defining an approach to determining higher risk areas for introduction of avian influenza virus into poultry or captive birds due to contact with infected wild birds to comply with Commission Decision (EU) 2018/1136 of 10 August 2018.
This guidance document provide information on the 2018/19 Community Pharmacy Contractual Framework National Audit, which is focused on the provision of seasonal influenza vaccination to people with diabetes.
This report examines the planning for the flu vaccination programme, how advice is formulated and cost-effectiveness issues are addressed, the reasons for different types of vaccines for different groups of the population, the effectiveness and take-up of the vaccination programme,
This letter, issued to providers of seasonal flu immunisation and other stakeholders, provides preliminary information on the recommended vaccines for the 2019/20 seasonal flu vaccination programme.
Fifth in a series of guides NHS England aimed to help health and social care colleagues to take prompt practical actions and use every opportunity to prevent delayed transfers of care. It aims to assist health and social care staff
Guidance for managing seasonal influenza, identifying pathogens and transmission routes for acute respiratory disease in care homes. This guidance covers: case definitions managing cases infection control recording and reporting
Guidance for local PHE Centre health protection teams about assessing and managing outbreaks of influenza-like illness (ILI) in schools including: preparedness measures investigation of outbreaks response measures
This document details local actions to ensure aTIV is offered to individuals aged 65 years and over.
This report focuses on results from the final end of season data submitted to PHE for children of school years reception to Year 4 between May and June 2018. The school-level data returns presented in this report include additional analysis on consents, refusals,
This letter to social care organisations confirms that NHS seasonal flu vaccination will continue in 2018/19 and will be extended to include health and care staff in the voluntary managed hospice sector that offer direct patient/client care as well as
This guideline covers how to increase uptake of the free flu vaccination among people who are eligible. It describes ways to increase awareness and how to use all opportunities in primary and secondary care to identify people who should be
Updated influenza immunisation information including updates for public health professionals. Influenza is an acute viral infection of the respiratory tract. There are 3 types of influenza virus: A, B and C. Influenza A and influenza B are responsible for most clinical illness. Influenza
This document about the inactivated influenza vaccine is intended for healthcare practitioners and includes detailed information on: the background of the programme vaccine handling, administration and constituents vaccine eligibility and precautions eligibility and resources to implement the programme
This leaflet explains to patients how they can help protect themselves and their children against flu this coming winter. It includes information for children, eligible adults and pregnant women, and explains why it’s very important that people at increased risk
This document sets out some key information to help general practices and pharmacies to plan for the 2018-19 flu vaccination season, and in particular to answer patient queries about the adjuvanted trivalent flu vaccine (aTIV).
This report focusses on some aspects Public Helath England’s Health and Justice team’s work during the 2017/18 financial year, specifically with regards to: prisons: including a new National Partnership Agreement on Prison Healthcare in England and supporting the Prison Estate Transformation Programme
Details a new economic model of the costs and benefits from flu vaccination in England using recent efficacy data. It introduces a conservative, static model which provides a partial cost-benefit analysis of vaccination under various scenarios. It also produces estimates of